SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-057712
Filing Date
2018-09-20
Accepted
2018-09-20 09:00:43
Documents
10
Period of Report
2018-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-30068_28k.htm 8-K 42158
2 EX-1.1 a18-30068_2ex1d1.htm EX-1.1 276468
3 EX-4.1 a18-30068_2ex4d1.htm EX-4.1 124974
4 EX-4.2 a18-30068_2ex4d2.htm EX-4.2 127804
5 EX-5.1 a18-30068_2ex5d1.htm EX-5.1 18960
6 EX-99.1 a18-30068_2ex99d1.htm EX-99.1 11229
7 EX-99.2 a18-30068_2ex99d2.htm EX-99.2 12223
8 GRAPHIC g300682moi001.jpg GRAPHIC 5429
9 GRAPHIC g300682mmi001.jpg GRAPHIC 5236
10 GRAPHIC g300682ksi001.jpg GRAPHIC 2502
  Complete submission text file 0001104659-18-057712.txt   633633
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 181078751
SIC: 3845 Electromedical & Electrotherapeutic Apparatus